Free Trial

Monopar Therapeutics (MNPR) SEC Filings & 10K Form

$0.81
-0.12 (-12.89%)
(As of 06/7/2024 ET)

Recent Monopar Therapeutics SEC Filings

DateFilerForm TypeView
06/05/2024
5:12 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:56 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
5:10 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
7:33 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
7:33 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
7:35 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
6:01 AM
Monopar Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2024
7:30 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
12:45 PM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
5:59 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
7:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
6:36 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:37 PM
Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:38 PM
KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:39 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:40 PM
Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:40 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:33 PM
Monopar Therapeutics (Issuer)
RIOUX PATRICE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:34 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
6:01 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
6:35 PM
Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:36 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:37 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:30 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:31 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:32 PM
Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
6:34 PM
KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
4:16 PM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Top 5 Tech Stocks to Buy for 2024 (Ad)

The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution…

Click below for your free report "Top 5 Tech Stocks to Buy in 2024",
07/11/2023
6:00 AM
Monopar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
5:45 PM
Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:46 PM
Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:46 PM
Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:49 PM
KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:49 PM
Brown Michael J (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:50 PM
Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
5:51 PM
Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MNPR) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners